공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

코로나바이러스 백신 시장 규모 : 백신 종류, 지역별 - 점유율, 전망, 기회 분석(2020-2027년)

Corona Virus Vaccine Market, by Vaccine Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

리서치사 Coherent Market Insights
발행일 2020년 12월 상품 코드 980005
페이지 정보 영문
가격
US $ 4,500 ₩ 5,075,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 7,894,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,278,000 PPT Turned PDF (Enterprise User License)


코로나바이러스 백신 시장 규모 : 백신 종류, 지역별 - 점유율, 전망, 기회 분석(2020-2027년) Corona Virus Vaccine Market, by Vaccine Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
발행일 : 2020년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 코로나바이러스 백신 시장 성장은 COVID-19 백신 생산과 유통을 늘리기 위한 주요 기업과 정부의 제휴/ 협업 등 무기적 성장 전략 채용 증가에 의해 예측기간 중 가속할 것으로 예측됩니다.

각국 정부는 마케팅과 상품화를 위해서 규제기관이 승인한 COVID-19 백신의 신속한 생산과 유통을 보장하기 위해 조취를 취하고 있습니다.

세계의 코로나바이러스 백신(Corona Virus Vaccine) 시장에 대해 조사했으며, 시장 기회와 동향, 성장 촉진요인 및 억제요인, 백신 종류·지역별 시장 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 조사 목적과 전제조건

제2장 시장 전망

  • 보고서 개요
    • 시장의 정의와 범위
  • 개요
    • 시장 개요 : 백신 유형별
    • 시장 개요 : 지역별
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 히트맵 분석
  • 시장 역학
    • 성장요인
    • 억제요인
    • 시장 기회
  • 규제 시나리오
  • 업계 동향
  • 인수합병(M&A)
  • 새로운 백신 형태 승인/발매
  • 프로모션 및 마케팅 이니셔티브
  • PEST 분석

제4장 시장 분석 : 백신 유형별(2016-2027년)

  • 서론
  • 불활성화 바이러스
  • 단백질 서브유닛
  • 비복제형 바이러스 벡터
  • 재이용 백신
  • RNA 백신
  • DNA 백신
  • 유전자 백신

제2장 시장 분석 : 지역별(2016-2027년)

  • 서론
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제3장 경쟁 구도

  • 히트맵 분석
  • 시장 점유율 분석
    • AstraZeneca plc
    • Pfizer Inc.
    • Sanofi SA
    • Novavax, Inc.
    • Moderna, Inc.
    • Sinovac Biotech Ltd.
    • Bharat Biotech International Limited
    • Johnson & Johnson
    • BioNTech SE
    • Serum Institute of India
    • Shanghai Fosun Pharmaceutical Group Co., Ltd.
    • CanSino Biologics Inc.
    • CureVac AG
    • Cadila Healthcare Limited
    • Arcturus Therapeutics Holdings Inc.
    • Entos Pharmaceuticals
    • Symvivo
  • 애널리스트의 견해

제4장 섹션

LSH 21.01.14

Title:
Corona Virus Vaccine Market, by Vaccine Type (Inactivated Virus, Protein Subunit, Non-replicating Viral Vector, Repurposed Vaccines, RNA Vaccine, DNA Vaccine, and Genetic Vaccines), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Government of various countries are taking actions, in order to ensure the rapid production and delivery of the COVID-19 vaccines once approved by regulatory authorities for marketing and commercialization. For instance, on May 15, 2020, the U.S. government announced Framework and Leadership for 'Operation Warp Speed', a national program to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics (medical countermeasures) in the U.S. The Operation Warp Speed's goal is to produce and deliver around 300 million doses of safe and effective COVID-19 vaccines with the initial doses available by January 2021 in the U.S. The Operation Warp Speed (OWS) is formed by the partnership of Department of Health and Human Services (HHS) such as Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), and the Department of Defense (DoD).

Market Dynamics

The increasing adoption of inorganic growth strategies such as partnerships and collaborations by key players, as well as by the government to increase the production and distribution of COVID-19 vaccines are expected to propel the market growth during the forecast period. For instance, on August 14, 2020, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) entered into an agreement with Moderna, Inc., to manufacture and deliver 100 million doses of COVID-19 vaccines produced by the company in the U.S by 2021.

Similarly, on October 16, 2020, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD) entered into an agreement with CVS and Walgreens to provide and administer COVID-19 vaccines to residents of long-term care facilities (LTCF) in the U.S. with no out-of-pocket costs.

Key features of the study:

  • This report provides in-depth analysis of the global corona virus vaccine market and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global corona virus vaccine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include AstraZeneca plc, Pfizer Inc., Sanofi S.A., Novavax, Inc., Moderna, Inc., Sinovac Biotech Ltd., Bharat Biotech International Limited, Johnson & Johnson, BioNTech SE, Serum Institute of India, Shanghai Fosun Pharmaceutical Group Co., Ltd., CanSino Biologics Inc., CureVac AG , Cadila Healthcare Limited, Arcturus Therapeutics Holdings Inc., Entos Pharmaceuticals, and Symvivo.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, Specimen Type up-gradation, market expansion, and marketing tactics
  • The global corona virus vaccine market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global corona virus vaccine market

Detailed Segmentation:

  • Global Corona Virus Vaccine Market, By Vaccine Type:
    • Inactivated Virus
    • Protein Subunit
    • Non-replicating Viral Vector
    • Repurposed Vaccines
    • RNA Vaccine
    • DNA Vaccine
    • Genetic Vaccines
  • Global Corona Virus Vaccine Market, By Region:
    • North America
      • By Vaccine Type
      • Inactivated Virus
      • Protein Subunit
      • Non-replicating Viral Vector
      • Repurposed Vaccines
      • RNA Vaccine
      • DNA Vaccine
      • Genetic Vaccines
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Vaccine Type
      • Inactivated Virus
      • Protein Subunit
      • Non-replicating Viral Vector
      • Repurposed Vaccines
      • RNA Vaccine
      • DNA Vaccine
      • Genetic Vaccines
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Vaccine Type
      • Inactivated Virus
      • Protein Subunit
      • Non-replicating Viral Vector
      • Repurposed Vaccines
      • RNA Vaccine
      • DNA Vaccine
      • Genetic Vaccines
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Vaccine Type
      • Inactivated Virus
      • Protein Subunit
      • Non-replicating Viral Vector
      • Repurposed Vaccines
      • RNA Vaccine
      • DNA Vaccine
      • Genetic Vaccines
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Vaccine Type
      • Inactivated Virus
      • Protein Subunit
      • Non-replicating Viral Vector
      • Repurposed Vaccines
      • RNA Vaccine
      • DNA Vaccine
      • Genetic Vaccines
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Vaccine Type
      • Inactivated Virus
      • Protein Subunit
      • Non-replicating Viral Vector
      • Repurposed Vaccines
      • RNA Vaccine
      • DNA Vaccine
      • Genetic Vaccines
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • AstraZeneca plc*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Pfizer Inc.
    • Sanofi S.A.
    • Novavax, Inc.
    • Moderna, Inc.
    • Sinovac Biotech Ltd.
    • Bharat Biotech International Limited
    • Johnson & Johnson
    • BioNTech SE
    • Serum Institute of India
    • Shanghai Fosun Pharmaceutical Group Co., Ltd.
    • CanSino Biologics Inc.
    • CureVac AG
    • Cadila Healthcare Limited
    • Arcturus Therapeutics Holdings Inc.
    • Entos Pharmaceuticals
    • Symvivo

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Vaccine Type
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Regulatory Scenario
  • Industry Trend
  • Merger and Acquisitions
  • New Vaccine Type Approvals/Launch
  • Promotion and Marketing Initiatives
  • PEST Analysis

4. Global Corona Virus Vaccine Market, By Vaccine Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Inactivated Virus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Protein Subunit
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Non-replicating Viral Vector
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Repurposed Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • RNA Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • DNA Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Genetic Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

2. Global Corona Virus Vaccine Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Vaccine Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Vaccine Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Vaccine Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Vaccine Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Vaccine Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Vaccine Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

3. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • AstraZeneca plc
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novavax, Inc.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Moderna, Inc.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sinovac Biotech Ltd.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bharat Biotech International Limited
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson & Johnson
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BioNTech SE
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Serum Institute of India
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Shanghai Fosun Pharmaceutical Group Co., Ltd.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CanSino Biologics Inc.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CureVac AG
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cadila Healthcare Limited
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Arcturus Therapeutics Holdings Inc.
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Entos Pharmaceuticals
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Symvivo
    • Company Overview
    • Vaccine Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

4. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top
전화 문의
F A Q